AURORA, Colo. -- Among those at low-risk for preterm birth, a blood-based biomarker screening test during the second ...

Getting at least 30 minutes of daily summer sun in the first year of life may mean a lower relapse risk for children who are ...

US-based biotechnology company Rallybio has dosed the first subject in a Phase II trial evaluating RLYB212 as a potential ...

A new study from Penn State University explored whether vitamin D levels across pregnancy are associated with birth outcomes ...

Rallybio (RLYB) announced that the first participant has been dosed in the Phase 2 trial investigating RLYB212 in pregnant women at higher risk ...